Inhibitory effect of Bacillus velezensis 1273 strain cell-free supernatant against developing and preformed biofilms of Staphylococcus aureus and MRSA
Microbial biofilms constitute a significant virulence factor and a substantial challenge in clinical environments due to their role in promoting antimicrobial resistance and their resilience to eradication efforts. Methicillin-resistant Staphylococcus aureus (MRSA) infections substantially increase...
Gespeichert in:
Veröffentlicht in: | Microbial pathogenesis 2024-12, Vol.197, p.107065, Article 107065 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | 107065 |
container_title | Microbial pathogenesis |
container_volume | 197 |
creator | Perini, Hugo Felix Pereira, Bianca de Barros Sousa, Eduarda Guimarães Matos, Beatriz Sodré Silva Prado, Ligia Carolina da Carvalho Azevedo, Vasco Ariston de Castro Soares, Siomar de Silva, Marcos Vinicius da |
description | Microbial biofilms constitute a significant virulence factor and a substantial challenge in clinical environments due to their role in promoting antimicrobial resistance and their resilience to eradication efforts. Methicillin-resistant Staphylococcus aureus (MRSA) infections substantially increase healthcare costs, extend hospitalizations, and elevate morbidity and mortality rates. Therefore, developing innovative strategies to target and eliminate these bacteria and their biofilms effectively is imperative for robust epidemiological control. In this study, we evaluated the antibacterial and antibiofilm activities of cell-free supernatant (CFS) obtained from the Bacillus velezensis 1273 strain culture. Our data showed that CFS inhibited the growth of S. aureus ATCC 29213 and MRSA (clinical strain), with greater efficacy observed against S. aureus (1:16 dilution). Furthermore, CFS showed substantial potential in reducing biofilm formation in both strains (∼30 %) at subinhibitory concentrations. Additionally, the antibacterial activity against biofilm-formed cells showed that pure CFS treatment decreased the viability of S. aureus (60 %) and MRSA (45 %) sessile cells. We further demonstrated that CFS treatment induces the production of reactive oxygen species (ROS) and damages the membranes and cell walls of the pathogen cells. Genome analysis revealed the presence of genes encoding bacteriocins and secondary metabolites with antibacterial activity in the B. velezensis 1273 genome. These findings highlight the potential of probiotic bacterial metabolites as antibiofilm and anti-multidrug-resistant pathogens.
[Display omitted]
•B. velezensis 1273 showed metabolites with antibacterial properties in its genome.•The CFS of B. velezensis inhibits the biofilm formation of S. aureus and MRSA.•The CFS induces cell death in pre-formed biofilms of S. aureus and MRSA.•The cell-free supernatant causes bacterial cell damage through oxidative stress. |
doi_str_mv | 10.1016/j.micpath.2024.107065 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3120597255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0882401024005321</els_id><sourcerecordid>3120597255</sourcerecordid><originalsourceid>FETCH-LOGICAL-c243t-9d613fc49a2e8bfdaf001118269386314f1dd7af520a144d342b6f167a9c69283</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS0EokPhEUBessngvzjxCpWqQKUiJApry7GvOx5l4mA7lYYH4XlxNANbVle6PsdH534IvaZkSwmV7_bbQ7CzKbstI0zUXUdk-wRtKFGyoYz0T9GG9D1rBKHkAr3IeU8IUYKr5-iCKyE6KfkG_b6ddmEIJaYjBu_BFhw9_mBsGMcl40cY4RdMOWRMWcdxLsmECVsYx8YnAJyXGdJkipkKNg_1LRfsoNriHKYHbCaH5wQ-pgM4PITow3jIa8R9MfPuOEYbra1BZkmwjqr_8u3-6iV65s2Y4dV5XqIfH2--X39u7r5-ur2-umssE7w0yknKvRXKMOgH74wnhFLaM6l4LzkVnjrXGd8yYqgQjgs2SE9lZ5SVivX8Er09_Tun-HOBXPQh5LWdmSAuWfN6yVZ1rG2rtD1JbYo51056TuFg0lFTolckeq_PSPSKRJ-QVN-bc8Qy1CP8c_1lUAXvTwKoRR8DJJ1tgMmCC6ny0C6G_0T8AV-XoYE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3120597255</pqid></control><display><type>article</type><title>Inhibitory effect of Bacillus velezensis 1273 strain cell-free supernatant against developing and preformed biofilms of Staphylococcus aureus and MRSA</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Perini, Hugo Felix ; Pereira, Bianca de Barros ; Sousa, Eduarda Guimarães ; Matos, Beatriz Sodré ; Silva Prado, Ligia Carolina da ; Carvalho Azevedo, Vasco Ariston de ; Castro Soares, Siomar de ; Silva, Marcos Vinicius da</creator><creatorcontrib>Perini, Hugo Felix ; Pereira, Bianca de Barros ; Sousa, Eduarda Guimarães ; Matos, Beatriz Sodré ; Silva Prado, Ligia Carolina da ; Carvalho Azevedo, Vasco Ariston de ; Castro Soares, Siomar de ; Silva, Marcos Vinicius da</creatorcontrib><description>Microbial biofilms constitute a significant virulence factor and a substantial challenge in clinical environments due to their role in promoting antimicrobial resistance and their resilience to eradication efforts. Methicillin-resistant Staphylococcus aureus (MRSA) infections substantially increase healthcare costs, extend hospitalizations, and elevate morbidity and mortality rates. Therefore, developing innovative strategies to target and eliminate these bacteria and their biofilms effectively is imperative for robust epidemiological control. In this study, we evaluated the antibacterial and antibiofilm activities of cell-free supernatant (CFS) obtained from the Bacillus velezensis 1273 strain culture. Our data showed that CFS inhibited the growth of S. aureus ATCC 29213 and MRSA (clinical strain), with greater efficacy observed against S. aureus (1:16 dilution). Furthermore, CFS showed substantial potential in reducing biofilm formation in both strains (∼30 %) at subinhibitory concentrations. Additionally, the antibacterial activity against biofilm-formed cells showed that pure CFS treatment decreased the viability of S. aureus (60 %) and MRSA (45 %) sessile cells. We further demonstrated that CFS treatment induces the production of reactive oxygen species (ROS) and damages the membranes and cell walls of the pathogen cells. Genome analysis revealed the presence of genes encoding bacteriocins and secondary metabolites with antibacterial activity in the B. velezensis 1273 genome. These findings highlight the potential of probiotic bacterial metabolites as antibiofilm and anti-multidrug-resistant pathogens.
[Display omitted]
•B. velezensis 1273 showed metabolites with antibacterial properties in its genome.•The CFS of B. velezensis inhibits the biofilm formation of S. aureus and MRSA.•The CFS induces cell death in pre-formed biofilms of S. aureus and MRSA.•The cell-free supernatant causes bacterial cell damage through oxidative stress.</description><identifier>ISSN: 0882-4010</identifier><identifier>ISSN: 1096-1208</identifier><identifier>EISSN: 1096-1208</identifier><identifier>DOI: 10.1016/j.micpath.2024.107065</identifier><identifier>PMID: 39447663</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibacterial ; Antibiotic resistance ; Bacillus - genetics ; Bacillus - metabolism ; Bacillus - physiology ; Bacteriocins - metabolism ; Bacteriocins - pharmacology ; Biofilms - drug effects ; Biofilms - growth & development ; Cell Wall - metabolism ; Methicillin-Resistant Staphylococcus aureus - drug effects ; Methicillin-Resistant Staphylococcus aureus - genetics ; Microbial Sensitivity Tests ; Microbial Viability - drug effects ; Pathogen ; Probiotic ; Reactive Oxygen Species - metabolism ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - genetics ; Staphylococcus aureus - physiology ; Virulence</subject><ispartof>Microbial pathogenesis, 2024-12, Vol.197, p.107065, Article 107065</ispartof><rights>2024 Elsevier Ltd</rights><rights>Copyright © 2024 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c243t-9d613fc49a2e8bfdaf001118269386314f1dd7af520a144d342b6f167a9c69283</cites><orcidid>0000-0003-1988-7273 ; 0000-0001-7299-3724 ; 0000-0001-8326-3612 ; 0009-0005-9227-3085</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.micpath.2024.107065$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39447663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Perini, Hugo Felix</creatorcontrib><creatorcontrib>Pereira, Bianca de Barros</creatorcontrib><creatorcontrib>Sousa, Eduarda Guimarães</creatorcontrib><creatorcontrib>Matos, Beatriz Sodré</creatorcontrib><creatorcontrib>Silva Prado, Ligia Carolina da</creatorcontrib><creatorcontrib>Carvalho Azevedo, Vasco Ariston de</creatorcontrib><creatorcontrib>Castro Soares, Siomar de</creatorcontrib><creatorcontrib>Silva, Marcos Vinicius da</creatorcontrib><title>Inhibitory effect of Bacillus velezensis 1273 strain cell-free supernatant against developing and preformed biofilms of Staphylococcus aureus and MRSA</title><title>Microbial pathogenesis</title><addtitle>Microb Pathog</addtitle><description>Microbial biofilms constitute a significant virulence factor and a substantial challenge in clinical environments due to their role in promoting antimicrobial resistance and their resilience to eradication efforts. Methicillin-resistant Staphylococcus aureus (MRSA) infections substantially increase healthcare costs, extend hospitalizations, and elevate morbidity and mortality rates. Therefore, developing innovative strategies to target and eliminate these bacteria and their biofilms effectively is imperative for robust epidemiological control. In this study, we evaluated the antibacterial and antibiofilm activities of cell-free supernatant (CFS) obtained from the Bacillus velezensis 1273 strain culture. Our data showed that CFS inhibited the growth of S. aureus ATCC 29213 and MRSA (clinical strain), with greater efficacy observed against S. aureus (1:16 dilution). Furthermore, CFS showed substantial potential in reducing biofilm formation in both strains (∼30 %) at subinhibitory concentrations. Additionally, the antibacterial activity against biofilm-formed cells showed that pure CFS treatment decreased the viability of S. aureus (60 %) and MRSA (45 %) sessile cells. We further demonstrated that CFS treatment induces the production of reactive oxygen species (ROS) and damages the membranes and cell walls of the pathogen cells. Genome analysis revealed the presence of genes encoding bacteriocins and secondary metabolites with antibacterial activity in the B. velezensis 1273 genome. These findings highlight the potential of probiotic bacterial metabolites as antibiofilm and anti-multidrug-resistant pathogens.
[Display omitted]
•B. velezensis 1273 showed metabolites with antibacterial properties in its genome.•The CFS of B. velezensis inhibits the biofilm formation of S. aureus and MRSA.•The CFS induces cell death in pre-formed biofilms of S. aureus and MRSA.•The cell-free supernatant causes bacterial cell damage through oxidative stress.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial</subject><subject>Antibiotic resistance</subject><subject>Bacillus - genetics</subject><subject>Bacillus - metabolism</subject><subject>Bacillus - physiology</subject><subject>Bacteriocins - metabolism</subject><subject>Bacteriocins - pharmacology</subject><subject>Biofilms - drug effects</subject><subject>Biofilms - growth & development</subject><subject>Cell Wall - metabolism</subject><subject>Methicillin-Resistant Staphylococcus aureus - drug effects</subject><subject>Methicillin-Resistant Staphylococcus aureus - genetics</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbial Viability - drug effects</subject><subject>Pathogen</subject><subject>Probiotic</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - genetics</subject><subject>Staphylococcus aureus - physiology</subject><subject>Virulence</subject><issn>0882-4010</issn><issn>1096-1208</issn><issn>1096-1208</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhS0EokPhEUBessngvzjxCpWqQKUiJApry7GvOx5l4mA7lYYH4XlxNANbVle6PsdH534IvaZkSwmV7_bbQ7CzKbstI0zUXUdk-wRtKFGyoYz0T9GG9D1rBKHkAr3IeU8IUYKr5-iCKyE6KfkG_b6ddmEIJaYjBu_BFhw9_mBsGMcl40cY4RdMOWRMWcdxLsmECVsYx8YnAJyXGdJkipkKNg_1LRfsoNriHKYHbCaH5wQ-pgM4PITow3jIa8R9MfPuOEYbra1BZkmwjqr_8u3-6iV65s2Y4dV5XqIfH2--X39u7r5-ur2-umssE7w0yknKvRXKMOgH74wnhFLaM6l4LzkVnjrXGd8yYqgQjgs2SE9lZ5SVivX8Er09_Tun-HOBXPQh5LWdmSAuWfN6yVZ1rG2rtD1JbYo51056TuFg0lFTolckeq_PSPSKRJ-QVN-bc8Qy1CP8c_1lUAXvTwKoRR8DJJ1tgMmCC6ny0C6G_0T8AV-XoYE</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Perini, Hugo Felix</creator><creator>Pereira, Bianca de Barros</creator><creator>Sousa, Eduarda Guimarães</creator><creator>Matos, Beatriz Sodré</creator><creator>Silva Prado, Ligia Carolina da</creator><creator>Carvalho Azevedo, Vasco Ariston de</creator><creator>Castro Soares, Siomar de</creator><creator>Silva, Marcos Vinicius da</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1988-7273</orcidid><orcidid>https://orcid.org/0000-0001-7299-3724</orcidid><orcidid>https://orcid.org/0000-0001-8326-3612</orcidid><orcidid>https://orcid.org/0009-0005-9227-3085</orcidid></search><sort><creationdate>202412</creationdate><title>Inhibitory effect of Bacillus velezensis 1273 strain cell-free supernatant against developing and preformed biofilms of Staphylococcus aureus and MRSA</title><author>Perini, Hugo Felix ; Pereira, Bianca de Barros ; Sousa, Eduarda Guimarães ; Matos, Beatriz Sodré ; Silva Prado, Ligia Carolina da ; Carvalho Azevedo, Vasco Ariston de ; Castro Soares, Siomar de ; Silva, Marcos Vinicius da</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c243t-9d613fc49a2e8bfdaf001118269386314f1dd7af520a144d342b6f167a9c69283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial</topic><topic>Antibiotic resistance</topic><topic>Bacillus - genetics</topic><topic>Bacillus - metabolism</topic><topic>Bacillus - physiology</topic><topic>Bacteriocins - metabolism</topic><topic>Bacteriocins - pharmacology</topic><topic>Biofilms - drug effects</topic><topic>Biofilms - growth & development</topic><topic>Cell Wall - metabolism</topic><topic>Methicillin-Resistant Staphylococcus aureus - drug effects</topic><topic>Methicillin-Resistant Staphylococcus aureus - genetics</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbial Viability - drug effects</topic><topic>Pathogen</topic><topic>Probiotic</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - genetics</topic><topic>Staphylococcus aureus - physiology</topic><topic>Virulence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perini, Hugo Felix</creatorcontrib><creatorcontrib>Pereira, Bianca de Barros</creatorcontrib><creatorcontrib>Sousa, Eduarda Guimarães</creatorcontrib><creatorcontrib>Matos, Beatriz Sodré</creatorcontrib><creatorcontrib>Silva Prado, Ligia Carolina da</creatorcontrib><creatorcontrib>Carvalho Azevedo, Vasco Ariston de</creatorcontrib><creatorcontrib>Castro Soares, Siomar de</creatorcontrib><creatorcontrib>Silva, Marcos Vinicius da</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Microbial pathogenesis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perini, Hugo Felix</au><au>Pereira, Bianca de Barros</au><au>Sousa, Eduarda Guimarães</au><au>Matos, Beatriz Sodré</au><au>Silva Prado, Ligia Carolina da</au><au>Carvalho Azevedo, Vasco Ariston de</au><au>Castro Soares, Siomar de</au><au>Silva, Marcos Vinicius da</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibitory effect of Bacillus velezensis 1273 strain cell-free supernatant against developing and preformed biofilms of Staphylococcus aureus and MRSA</atitle><jtitle>Microbial pathogenesis</jtitle><addtitle>Microb Pathog</addtitle><date>2024-12</date><risdate>2024</risdate><volume>197</volume><spage>107065</spage><pages>107065-</pages><artnum>107065</artnum><issn>0882-4010</issn><issn>1096-1208</issn><eissn>1096-1208</eissn><abstract>Microbial biofilms constitute a significant virulence factor and a substantial challenge in clinical environments due to their role in promoting antimicrobial resistance and their resilience to eradication efforts. Methicillin-resistant Staphylococcus aureus (MRSA) infections substantially increase healthcare costs, extend hospitalizations, and elevate morbidity and mortality rates. Therefore, developing innovative strategies to target and eliminate these bacteria and their biofilms effectively is imperative for robust epidemiological control. In this study, we evaluated the antibacterial and antibiofilm activities of cell-free supernatant (CFS) obtained from the Bacillus velezensis 1273 strain culture. Our data showed that CFS inhibited the growth of S. aureus ATCC 29213 and MRSA (clinical strain), with greater efficacy observed against S. aureus (1:16 dilution). Furthermore, CFS showed substantial potential in reducing biofilm formation in both strains (∼30 %) at subinhibitory concentrations. Additionally, the antibacterial activity against biofilm-formed cells showed that pure CFS treatment decreased the viability of S. aureus (60 %) and MRSA (45 %) sessile cells. We further demonstrated that CFS treatment induces the production of reactive oxygen species (ROS) and damages the membranes and cell walls of the pathogen cells. Genome analysis revealed the presence of genes encoding bacteriocins and secondary metabolites with antibacterial activity in the B. velezensis 1273 genome. These findings highlight the potential of probiotic bacterial metabolites as antibiofilm and anti-multidrug-resistant pathogens.
[Display omitted]
•B. velezensis 1273 showed metabolites with antibacterial properties in its genome.•The CFS of B. velezensis inhibits the biofilm formation of S. aureus and MRSA.•The CFS induces cell death in pre-formed biofilms of S. aureus and MRSA.•The cell-free supernatant causes bacterial cell damage through oxidative stress.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>39447663</pmid><doi>10.1016/j.micpath.2024.107065</doi><orcidid>https://orcid.org/0000-0003-1988-7273</orcidid><orcidid>https://orcid.org/0000-0001-7299-3724</orcidid><orcidid>https://orcid.org/0000-0001-8326-3612</orcidid><orcidid>https://orcid.org/0009-0005-9227-3085</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0882-4010 |
ispartof | Microbial pathogenesis, 2024-12, Vol.197, p.107065, Article 107065 |
issn | 0882-4010 1096-1208 1096-1208 |
language | eng |
recordid | cdi_proquest_miscellaneous_3120597255 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Anti-Bacterial Agents - pharmacology Antibacterial Antibiotic resistance Bacillus - genetics Bacillus - metabolism Bacillus - physiology Bacteriocins - metabolism Bacteriocins - pharmacology Biofilms - drug effects Biofilms - growth & development Cell Wall - metabolism Methicillin-Resistant Staphylococcus aureus - drug effects Methicillin-Resistant Staphylococcus aureus - genetics Microbial Sensitivity Tests Microbial Viability - drug effects Pathogen Probiotic Reactive Oxygen Species - metabolism Staphylococcus aureus - drug effects Staphylococcus aureus - genetics Staphylococcus aureus - physiology Virulence |
title | Inhibitory effect of Bacillus velezensis 1273 strain cell-free supernatant against developing and preformed biofilms of Staphylococcus aureus and MRSA |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T21%3A41%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibitory%20effect%20of%20Bacillus%20velezensis%201273%20strain%20cell-free%20supernatant%20against%20developing%20and%20preformed%20biofilms%20of%20Staphylococcus%20aureus%20and%20MRSA&rft.jtitle=Microbial%20pathogenesis&rft.au=Perini,%20Hugo%20Felix&rft.date=2024-12&rft.volume=197&rft.spage=107065&rft.pages=107065-&rft.artnum=107065&rft.issn=0882-4010&rft.eissn=1096-1208&rft_id=info:doi/10.1016/j.micpath.2024.107065&rft_dat=%3Cproquest_cross%3E3120597255%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3120597255&rft_id=info:pmid/39447663&rft_els_id=S0882401024005321&rfr_iscdi=true |